- Home
- GGN vs LAB Comparison
GGN vs LAB Comparison
Compare GGN & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GGN
- LAB
- Stock Information
- Founded
- GGN 2005
- LAB 1999
- Country
- GGN United States
- LAB United States
- Employees
- GGN N/A
- LAB N/A
- Industry
- GGN Finance/Investors Services
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- GGN Finance
- LAB Industrials
- Exchange
- GGN Nasdaq
- LAB Nasdaq
- Market Cap
- GGN 643.9M
- LAB 562.1M
- IPO Year
- GGN N/A
- LAB 2011
- Fundamental
- Price
- GGN $4.39
- LAB $1.08
- Analyst Decision
- GGN
- LAB Strong Buy
- Analyst Count
- GGN 0
- LAB 3
- Target Price
- GGN N/A
- LAB $2.88
- AVG Volume (30 Days)
- GGN 397.4K
- LAB 1.5M
- Earning Date
- GGN 01-01-0001
- LAB 05-07-2025
- Dividend Yield
- GGN 10.26%
- LAB N/A
- EPS Growth
- GGN N/A
- LAB N/A
- EPS
- GGN N/A
- LAB N/A
- Revenue
- GGN N/A
- LAB $174,432,000.00
- Revenue This Year
- GGN N/A
- LAB N/A
- Revenue Next Year
- GGN N/A
- LAB $12.77
- P/E Ratio
- GGN N/A
- LAB N/A
- Revenue Growth
- GGN N/A
- LAB 64.03
- 52 Week Low
- GGN $3.51
- LAB $0.99
- 52 Week High
- GGN $3.91
- LAB $3.04
- Technical
- Relative Strength Index (RSI)
- GGN 69.17
- LAB 39.47
- Support Level
- GGN $4.05
- LAB $1.11
- Resistance Level
- GGN $4.37
- LAB $1.21
- Average True Range (ATR)
- GGN 0.05
- LAB 0.07
- MACD
- GGN 0.01
- LAB 0.01
- Stochastic Oscillator
- GGN 98.33
- LAB 14.24
About GGN GAMCO Global Gold Natural Resources & Income Trust
GAMCO Global Gold Natural Resources & Income Trust is a non-diversified closed-end management investment company. Its primary investment objective is to provide a high current income and capital appreciation as its secondary objective. To achieve its objective, the fund may invest majority of its assets in equity securities of companies principally engaged in the gold and natural resources industries. It also intends to earn income through an option strategy of writing (selling) covered call options on equity securities in its portfolio.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.